Inhibition of Shikimate Kinase and Type II Dehydroquinase for Antibiotic Discovery: Structure-Based Design and Simulation Studies

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|16|9|960-977

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.16, Iss.9, 2016-04, pp. : 960-977

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Structure-based Drugs Design Studies on Spleen Tyrosine Kinase Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 9, 2016-11 ,pp. : 845-858

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-based design, discovery and development of checkpoint kinase inhibitors as potential anticancer therapies

By Matthews Thomas P   Jones Alan M   Collins Ian  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 6, 2013-10 ,pp. : 621-640

Informa Healthcare

Access to resources Recommend Favorite

Structure-and-Mechanism-Based Design and Discovery of Type II Mycobacterium Tuberculosis Dehydroquinate Dehydratase Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 1, 2014-01 ,pp. : 51-63

Bentham Science Publishers

Access to resources Recommend Favorite

Glutamate Carboxypeptidase II: An Overview of Structural Studies and Their Importance for Structure-Based Drug Design and Deciphering the Reaction Mechanism of the Enzyme

By  

Current Medicinal Chemistry, Vol. 19, Iss. 9, 2012-03 ,pp. : 1300-1309

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in Computational Structure-Based Drug Design and Application in Drug Discovery

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 9, 2016-04 ,pp. : 901-916

Bentham Science Publishers

Access to resources Recommend Favorite